Silvant Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,731
| Closed | -$2.16M | – | 339 |
|
|
2021
Q2 | $2.16M | Sell |
10,731
-186
| -2% | -$37.5K | 0.34% | 71 |
|
|
2021
Q1 | $2.35M | Sell |
10,917
-345
| -3% | -$74.1K | 0.4% | 65 |
|
|
2020
Q4 | $2.66M | Buy |
11,262
+96
| +0.9% | +$22.7K | 0.45% | 57 |
|
|
2020
Q3 | $3.04M | Sell |
11,166
-2,995
| -21% | -$815K | 0.57% | 41 |
|
|
2020
Q2 | $4.11M | Sell |
14,161
-949
| -6% | -$275K | 0.74% | 30 |
|
|
2020
Q1 | $3.6M | Sell |
15,110
-299
| -2% | -$71.2K | 0.78% | 28 |
|
|
2019
Q4 | $3.37M | Sell |
15,409
-189
| -1% | -$41.4K | 0.62% | 46 |
|
|
2019
Q3 | $2.64M | Sell |
15,598
-2,130
| -12% | -$361K | 0.52% | 58 |
|
|
2019
Q2 | $3.25M | Sell |
17,728
-1,686
| -9% | -$309K | 0.58% | 53 |
|
|
2019
Q1 | $3.57M | Sell |
19,414
-815
| -4% | -$150K | 0.64% | 47 |
|
|
2018
Q4 | $3.35M | Sell |
20,229
-601
| -3% | -$99.6K | 0.67% | 48 |
|
|
2018
Q3 | $4.02M | Sell |
20,830
-3,492
| -14% | -$673K | 0.5% | 73 |
|
|
2018
Q2 | $4.13M | Sell |
24,322
-285
| -1% | -$48.4K | 0.51% | 74 |
|
|
2018
Q1 | $4.01M | Buy |
+24,607
| New | +$4.01M | 0.51% | 74 |
|